Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. 'The healthcare system was just trying to deal with me without really dealing with me': exploring individual experiences of methamphetamine-related emergency department visits in Calgary - a qualitative study.BMJ open · 2026
   Article
2. Trends of incident stimulant use disorder diagnoses before and after the COVID-19 pandemic in British Columbia (2013-2024): a population-based study.Frontiers in psychiatry · 2026
   Article
3. Challenges and opportunities in embedding core components of substance use health care into Housing First programs.Frontiers in public health · 2026
   Article
4. Urgent response is needed to address the stimulant-fentanyl related overdose crisis.Frontiers in psychiatry · 2026
   Article
5. Interventions for stimulant use in people who are homeless or vulnerably housed: a scoping review of the evidence including trauma-informed approaches.Harm reduction journal · 2025
   Article
6. Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study.Drug and alcohol review · 2025
   Article
7. Vigilance needed with methamphetamine-associated psychosis.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
   Article
8. The authors respond to letters on using prescribed psychostimulants to treat stimulant use disorder.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
   Article
9. Critical examination of incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
   Article
10. Evidence base to support using prescribed psychostimulants to treat psychostimulant use disorder is limited.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
    Article

Corrections and comments

• Commented on by
  Critical examination of incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada.2023
• Commented on by
  Evidence base to support using prescribed psychostimulants to treat psychostimulant use disorder is limited.2023
• Commented on by
  Vigilance needed with methamphetamine-associated psychosis.2023

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as